l9n/ Oregon

2020 Regular Session

Senate Bill 1535

Requires Department of Consumer and Business Services to investigate methods for collecting information about rebates and markups used in pharmaceutical supply chain and to report to interim committees of Legislative Assembly recommendations for collecting information.

Did not become law. It stopped in the House of Representatives on March 8, 2020. The 2020 session has ended.

What it does

The synopsis the Legislative Assembly published with the bill.

Requires Department of Consumer and Business Services to investigate methods for collecting information about rebates and markups used in pharmaceutical supply chain and to report to interim committees of Legislative Assembly recommendations for collecting information. Authorizes department to access, use and disclose data from all payer, all claims database under specified conditions. Modifies increase in price of prescription drug that triggers pharmaceutical manufacturer's obligation to report data under Prescription Drug Price Transparency Act. <i>Requires prescription drug manufacturers to respond promptly to requests by department in administering Prescription Drug Price Transparency Act.</i>] Allows department to disclose information about consumers' notifications of increases in prices of prescription drugs but not personally identifiable information about consumers. Modifies membership of, charge to and reporting requirements for Task Force on the Fair Pricing of Prescription Drugs. Extends sunset of task force to December 31, 2022. Declares emergency, effective on passage.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

1 co-sponsor

Chuck Riley

In the House of Representatives

1 co-sponsor

Alissa Keny-Guyer

Its course

January 27 to March 8, 2020, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action20 actions on 13 days

In the SenateJan 27 to Feb 2024 days

Waiting for a committeeJan 27 to Feb 37 days

Health CareFeb 3 to Feb 1714 days

In the House of RepresentativesFeb 20 to Mar 8 · stopped17 days

Waiting for a committeeFeb 20 to Feb 211 day

RulesFeb 21 to Feb 287 days

Votes

Yeas to nays, as the Legislative Assembly recorded them. Committee votes are set in.

  • Senate, third reading11–18

    Feb 20 · 1 present

  • Senate, third reading19–10

    Passed · Feb 20 · 1 present

Amendments

Each amendment offered, and what became of it.

  • Senate committee amendmentAdopted

    Adopted Feb 17

  • House of Representatives committee amendmentAdopted

    Adopted Feb 28

Text

Each version as the Legislative Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

In the Senate Jan 27 – Feb 20

  1. Filed before the session
  2. Introduced
  3. Sent to Health Care
  4. Heard in Health Care
  5. Heard in Health Care
  6. Heard in Health Care
  7. Health Care recommended it as amended
  8. Read a second time
  9. Passed the Senate, 19 to 10

In the House of Representatives Feb 21 – Mar 8

  1. Arrived in the House of Representatives
  2. Sent to Rules
  3. Heard in Rules
  4. Heard in Rules
  5. Rules recommended it as amended
  6. Died when the session ended
All 20 actions, as published